SEI Investments’s Editas Medicine EDIT Stock Holding History

SEI Investments’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Sell	68,268 -20,439	-23%	-$59.7K	﹤0.01%	3009
2026 Q1	$219K	Buy	88,707 +14,516	+20%	+$30.7K	﹤0.01%	2945
2025 Q4	$152K	Buy	74,191 +60,879	+457%	+$176K	﹤0.01%	2965
2025 Q3	$46.2K	Buy	+13,312	New	+$37.2K	﹤0.01%	2786
2025 Q2	–	Sell	-83,158	Closed	-$96.5K	–	2822
2025 Q1	$96.5K	Hold	83,158	–	–	﹤0.01%	2601
2024 Q4	$106K	Buy	+83,158	New	+$212K	﹤0.01%	2571
2021 Q2	–	Sell	-23,392	Closed	-$1.63M	–	2562
2021 Q1	$1.63M	Hold	23,392	–	–	﹤0.01%	1552
2020 Q4	$1.63M	Buy	+23,392	New	+$961K	﹤0.01%	1481
2019 Q2	–	Sell	-41,625	Closed	-$1.05M	–	2490
2019 Q1	$1.05M	Buy	+41,625	New	+$942K	﹤0.01%	1582
2018 Q3	–	Sell	-800	Closed	-$29K	–	2707
2018 Q2	$29K	Sell	800 -1,650	-67%	-$58.4K	﹤0.01%	2675
2018 Q1	$82K	Buy	+2,450	New	+$87.3K	﹤0.01%	2194

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SEI Investments's EDIT Position: Q2 2026 in Review

SEI Investments reduced its Editas Medicine (EDIT) stake by 23% in Q2 2026, selling an estimated $59.7K and leaving 68,268 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #3009.

SEI Investments first reported a position in EDIT in Q1 2018 and has held it in 11 quarters since. The position peaked at $1.63M in Q1 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

SEI Investments held 68,268 shares of Editas Medicine worth $221K as of Q2 2026.
SEI Investments sold 20,439 Editas Medicine shares in Q2 2026, an estimated $59.7K.
Editas Medicine made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3009 holding.
SEI Investments first reported a position in Editas Medicine in Q1 2018 and has held it in 11 quarters since.
SEI Investments's Editas Medicine position peaked at $1.63M in Q1 2021.
214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.